Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study.

MLA

Mounier, Roman, et al. “Clinical Outcome of Wild-Type AmpC-Producing Enterobacterales Infection in Critically Ill Patients Treated with β-Lactams: A Prospective Multicenter Study.” Annals of Intensive Care, vol. 12, no. 1, Nov. 2022, p. 107. EBSCOhost, https://doi.org/10.1186/s13613-022-01079-5.

APA

Mounier, R., Le Guen, R., Woerther, P.-L., Nacher, M., Bonnefon, C., Mongardon, N., Langeron, O., Levesque, E., Couffin, S., Houcke, S., Wolff, M., Roujansky, A., Schimpf, C., Mekontso Dessap, A., Cook, F., Razazi, K., & Kallel, H. (2022). Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study. Annals of Intensive Care, 12(1), 107. https://doi.org/10.1186/s13613-022-01079-5

Chicago

Mounier, Roman, Ronan Le Guen, Paul-Louis Woerther, Mathieu Nacher, Clément Bonnefon, Nicolas Mongardon, Olivier Langeron, et al. 2022. “Clinical Outcome of Wild-Type AmpC-Producing Enterobacterales Infection in Critically Ill Patients Treated with β-Lactams: A Prospective Multicenter Study.” Annals of Intensive Care 12 (1): 107. doi:10.1186/s13613-022-01079-5.